| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.002 | 0.9 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.0078 | 1 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.0041 | 1 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |